TCR2 Therapeutics Inc.
TCRR · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $38,582 | $176,780 | $865,748 | $301,368 |
| - Cash | $32,746 | $222,564 | $94,155 | $65,296 |
| + Debt | $53,761 | $26,363 | $0 | $0 |
| Enterprise Value | $59,597 | -$19,421 | $771,593 | $236,072 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$89,619 | -$96,915 | -$67,108 | -$50,520 |
| % Margin | – | – | – | – |
| Net Income | -$151,822 | -$99,807 | -$67,124 | -$47,599 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.93 | -2.63 | -2.4 | -2.26 |
| % Growth | -49.4% | -9.6% | -6.2% | – |
| Operating Cash Flow | -$101,461 | -$81,603 | -$56,739 | -$41,359 |
| Capital Expenditures | -$15,452 | -$11,449 | -$7,164 | -$3,879 |
| Free Cash Flow | -$116,913 | -$93,052 | -$63,903 | -$45,238 |